FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386272065> ?p ?o ?g. }

• W4386272065 endingPage "E375" @default.
• W4386272065 startingPage "E363" @default.
• W4386272065 abstract "Cancer-related fatigue (CRF) is one of the most common complications in patients with multiple cancer types and severely affects patients' quality of life. However, there have only been single symptom-relieving adjuvant therapies but no effective pharmaceutical treatment for the CRF syndrome. Dichloroacetate (DCA), a small molecule inhibitor of pyruvate dehydrogenase kinase, has been tested as a potential therapy to slow tumor growth, based largely on its effects in vitro to halt cell division. We found that although DCA did not affect rates of tumor growth or the efficacy of standard cancer treatment (immunotherapy and chemotherapy) in two murine cancer models, DCA preserved physical function in mice with late-stage tumors by reducing circulating lactate concentrations. In vivo liquid chromatography-mass spectrometry/mass spectrometry studies suggest that DCA treatment may preserve membrane potential, postpone proteolysis, and relieve oxidative stress in muscles of tumor-bearing mice. In all, this study provides evidence for DCA as a novel pharmaceutical treatment to maintain physical function and motivation in murine models of CRF.NEW & NOTEWORTHY We identify a new metabolic target for cancer-related fatigue, dichloroacetate (DCA). They demonstrate that in mice, DCA preserves physical function and protects against the detrimental effects of cancer treatment by reducing cancer-induced increases in circulating lactate. As DCA is already FDA approved for another indication, these results could be rapidly translated to clinical trials for this condition for which no pharmaceutical therapies exist beyond symptom management." @default.
• W4386272065 created "2023-08-31" @default.
• W4386272065 creator A5003712477 @default.
• W4386272065 creator A5010719417 @default.
• W4386272065 creator A5022149962 @default.
• W4386272065 creator A5024869042 @default.
• W4386272065 creator A5038336843 @default.
• W4386272065 creator A5039545694 @default.
• W4386272065 creator A5044191705 @default.
• W4386272065 creator A5047813787 @default.
• W4386272065 creator A5050621189 @default.
• W4386272065 creator A5053467552 @default.
• W4386272065 creator A5072581220 @default.
• W4386272065 date "2023-10-01" @default.
• W4386272065 modified "2023-10-15" @default.
• W4386272065 title "Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma" @default.
• W4386272065 cites W1952315861 @default.
• W4386272065 cites W1966392686 @default.
• W4386272065 cites W1981737547 @default.
• W4386272065 cites W1989139859 @default.
• W4386272065 cites W1997052254 @default.
• W4386272065 cites W2018971639 @default.
• W4386272065 cites W2020159092 @default.
• W4386272065 cites W2032234772 @default.
• W4386272065 cites W2034246868 @default.
• W4386272065 cites W2046687522 @default.
• W4386272065 cites W2052971191 @default.
• W4386272065 cites W2055366832 @default.
• W4386272065 cites W2072451938 @default.
• W4386272065 cites W2072580848 @default.
• W4386272065 cites W2073658789 @default.
• W4386272065 cites W2091917093 @default.
• W4386272065 cites W2092271538 @default.
• W4386272065 cites W2113798680 @default.
• W4386272065 cites W2116868957 @default.
• W4386272065 cites W2133244276 @default.
• W4386272065 cites W2149279554 @default.
• W4386272065 cites W2150471053 @default.
• W4386272065 cites W2153616752 @default.
• W4386272065 cites W2155056971 @default.
• W4386272065 cites W2163763269 @default.
• W4386272065 cites W2170121279 @default.
• W4386272065 cites W2170518490 @default.
• W4386272065 cites W2553135190 @default.
• W4386272065 cites W2559931951 @default.
• W4386272065 cites W2593266874 @default.
• W4386272065 cites W2604145804 @default.
• W4386272065 cites W2607301376 @default.
• W4386272065 cites W2610435987 @default.
• W4386272065 cites W2765303057 @default.
• W4386272065 cites W2790831669 @default.
• W4386272065 cites W2898331318 @default.
• W4386272065 cites W2911885342 @default.
• W4386272065 cites W2948200417 @default.
• W4386272065 cites W2957553191 @default.
• W4386272065 cites W2990089967 @default.
• W4386272065 cites W3047104495 @default.
• W4386272065 cites W3091348560 @default.
• W4386272065 cites W3106279396 @default.
• W4386272065 cites W4206408839 @default.
• W4386272065 cites W4214813287 @default.
• W4386272065 cites W4220811415 @default.
• W4386272065 cites W4234224939 @default.
• W4386272065 cites W4280588360 @default.
• W4386272065 cites W4310522733 @default.
• W4386272065 cites W4383337748 @default.
• W4386272065 doi "https://doi.org/10.1152/ajpendo.00105.2023" @default.
• W4386272065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37646579" @default.
• W4386272065 hasPublicationYear "2023" @default.
• W4386272065 type Work @default.
• W4386272065 citedByCount "0" @default.
• W4386272065 crossrefType "journal-article" @default.
• W4386272065 hasAuthorship W4386272065A5003712477 @default.
• W4386272065 hasAuthorship W4386272065A5010719417 @default.
• W4386272065 hasAuthorship W4386272065A5022149962 @default.
• W4386272065 hasAuthorship W4386272065A5024869042 @default.
• W4386272065 hasAuthorship W4386272065A5038336843 @default.
• W4386272065 hasAuthorship W4386272065A5039545694 @default.
• W4386272065 hasAuthorship W4386272065A5044191705 @default.
• W4386272065 hasAuthorship W4386272065A5047813787 @default.
• W4386272065 hasAuthorship W4386272065A5050621189 @default.
• W4386272065 hasAuthorship W4386272065A5053467552 @default.
• W4386272065 hasAuthorship W4386272065A5072581220 @default.
• W4386272065 hasConcept C121608353 @default.
• W4386272065 hasConcept C126322002 @default.
• W4386272065 hasConcept C143998085 @default.
• W4386272065 hasConcept C150903083 @default.
• W4386272065 hasConcept C207001950 @default.
• W4386272065 hasConcept C2776151105 @default.
• W4386272065 hasConcept C2777658100 @default.
• W4386272065 hasConcept C2777701055 @default.
• W4386272065 hasConcept C2777863537 @default.
• W4386272065 hasConcept C2778141389 @default.
• W4386272065 hasConcept C502942594 @default.
• W4386272065 hasConcept C535046627 @default.
• W4386272065 hasConcept C71924100 @default.
• W4386272065 hasConcept C86803240 @default.
• W4386272065 hasConcept C96232424 @default.

• next